Last edition
News about "Cancer Treatment"
Immorta Bio Reports Tumour Reduction Across Multiple Cancer Models with SenoVax
Immorta Bio has reported promising pre-clinical results showing that its anti-aging vaccine, SenoVax, reduced tumours across multiple validated cancer models. Developed in collaboration with academic institutions, the platform aims to dismantle tumour defense mechanisms and offer a non-toxic, longevity-driven approach to cancer treatment.
Cancer Treatment | 05/12/2025 | By Dineshwori
Innovent Biologics and Takeda Finalise Global Collaboration for Next-Generation IO and ADC Therapies
As part of the agreement, Takeda will pay Innovent an upfront payment of USD1.2 billion, including a USD100 million equity investment at HKD112.56 per share.
Cancer Treatment | 05/12/2025 | By Dineshwori
Accession Therapeutics Doses First Patient in Phase 1 Trial of TROCEPT-01
Accession Therapeutics has dosed the first patient in its Phase 1 trial of TROCEPT-01 (ATTR-01), a first-in-class tumour-activated viral immunotherapy. Designed for systemic delivery, the therapy aims to selectively generate a checkpoint inhibitor within tumours, offering a targeted approach to cancer treatment.
Cancer Treatment | 18/11/2025 | By Dineshwori
Bayer and Kumquat Biosciences have begun a Phase-I trial of their KRAS G12D inhibitor targeting KRAS-mutated tumors, further bolstering Bayer’s precision oncology pipeline across pancreatic, colorectal, and lung cancers.
Cancer Treatment | 11/10/2025 | By Dineshwori | 366
Nucleus RadioPharma Receives Series A Extension Funding from AstraZeneca
Nucleus RadioPharma has closed its Series A extension round with new investor AstraZeneca.
Cancer Treatment | 06/06/2024 | By Aishwarya | 590
New patent grant to OSE Immunotherapeutics by EPO
OSE Immunotherapeutics receives European patent covering novel myeloid immune checkpoint target, CLEC-1 for cancer treatment
Cancer Treatment | 03/05/2022 | By Sudeep Soparkar | 819
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy